WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Innoviva revenue was $370.23M for the trailing 12 months ending Jun 30, 2025, with -72.9% growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $100.3M, up 13.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INVA annual revenue was $358.7M, with 15.5% growth year-over-year.

INVA past revenue growth

How has INVA's revenue growth performed historically?

Company
12.02%
Industry
148.77%
Market
20.34%
INVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INVA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INVA revenue history

Current Revenue
$370.2M
Current Earnings
$38.6M
Current Profit Margin
10.4%

Be the first to know when INVA announces revenue.

INVA Revenue History By Year

INVA Yearly RevenueINVA RevenueINVA ChangeINVA Revenue Growth
2024-12-31$358.71M$48.25M+15.54%
2023-12-31$310.46M-$20.88M-6.30%
2022-12-31$331.34M-$60.53M-15.45%
2021-12-31$391.87M$55.07M+16.35%
2020-12-31$336.79M$75.78M+29.03%
2019-12-31$261.02M$12.00k+0.00%
2018-12-31$261.00M$43.79M+20.16%
2017-12-31$217.22M$83.65M+62.63%
2016-12-31$133.57M$79.62M+147.58%
2015-12-31$53.95M$45.52M+539.74%
2014-12-31$8.43M$3.90M+86.08%
2013-12-31$4.53M-$1.08M-19.26%
2012-12-31$5.61M-$18.90M-77.10%
2011-12-31$24.51M$289.00k+1.19%
2010-12-31$24.22M-$151.00k-0.62%
2009-12-31$24.37M$1.28M+5.53%
2008-12-31$23.10M$1.09M+4.97%
2007-12-31$22.00M$2.42M+12.33%
2006-12-31$19.59M$7.53M+62.49%
2005-12-31$12.05M$3.11M+34.83%
2004-12-31$8.94M$5.34M+147.99%
2003-12-31$3.61M$3.45M+2,210.90%
2002-12-31$156.00kN/AN/A
2001-12-31$0.00N/AN/A

1 of 2

Innoviva Revenue FAQ

What was INVA's revenue last quarter?

On Invalid Date, Innoviva (NASDAQ: INVA) reported Q2 2025 revenue of $100.28 million up 0.39% year over year. In the same quarter last year, Innoviva's revenue was $99.90 million.

What was Innoviva's revenue in 2024?

Innoviva's annual revenue for the twelve months ending Dec 31, 2024 was $358.71 million, a 15.54% increase year over year.

How much does Innoviva make in a day?

Based on Innoviva annual revenue for the past five years, INVA makes an average of $947,492.05 per day.

What was Innoviva's annual revenue growth in the past year?

As of Q4 2025, Innoviva's revenue has grown 12.02% year over year. This is 136.74 percentage points lower than the US Biotechnology industry revenue growth rate of 148.77%. Innoviva's revenue in the past year totaled $370.23 million.

How much does Innoviva make in a year?

Innoviva's revenue by year for the past five years is:
  • Innoviva's revenue for the twelve months ending Dec 31, 2024 was $358.71 million, a 15.54% increase year over year.
  • Innoviva's annual revenue for Dec 31, 2023 was $310.46 million, a 6.3% decrease from 2022.
  • Innoviva's annual revenue for 2022 was $331.34 million, a 15.45% decrease from 2021.
  • Innoviva's annual revenue for 2021 was $391.87 million, a 16.35% increase from 2020.
  • Innoviva's annual revenue for 2020 was $336.79 million, a 29.03% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.